BRPI0408365A - compostos heterocìclicos de imunomodulação - Google Patents
compostos heterocìclicos de imunomodulaçãoInfo
- Publication number
- BRPI0408365A BRPI0408365A BRPI0408365-2A BRPI0408365A BRPI0408365A BR PI0408365 A BRPI0408365 A BR PI0408365A BR PI0408365 A BRPI0408365 A BR PI0408365A BR PI0408365 A BRPI0408365 A BR PI0408365A
- Authority
- BR
- Brazil
- Prior art keywords
- optionally substituted
- alq
- alkyl
- radical
- heterocyclic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Surgery (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Emergency Medicine (AREA)
- Transplantation (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
"COMPOSTOS HETEROCìCLICOS DE IMUNOMODULAçãO". A presente invenção refere-se a compostos da fórmula (I) são inibidores de CD80 e úteis na terapia de imunomodulação: R~ 1~ e R~ 3~ representam, independentemente H; F, CI; Br; -NO~ 2~; -CN; C~ 1-6~ alquila opcionalmente substituída por F ou CI; ou C~ 1~-C~ 6~ alcóxi, opcionalmente substituído por F; R~ 4~ representa um grupo de ácido carboxílico (-COOH) ou um éster do mesmo, ou -C(=O)NR~ 6~R~ 7~, -NR~ 7~C(=O)R~ 6~, -NR~ 7~C(=O)OR~ 6~, NHC(=O)NR~ 7~R 6~ ou NHC(=S)NR~ 7~R~ 6~ onde: R~ 6~ representa H ou um radical da fórmula -(Alq)~ m~-Q, onde: m é 0 ou 1; Alq é UM C~ 1~-C~ 12~ alquileno divalente, opcionalmente substituído, linear ou ramificado, ou radical C~ 2~-C~ 12~ alquenileno ou C~ 2~-C~ 12~ alquinileno ou um radical divalente C~ 3~-C~ 12~ carboxílico, qualquer um dos quais pode conter uma ou mais das ligações -O-, -S- ou -N(R~ 8~)onde R~ 8~ representa H ou C~ 1~-C~ 4~ alquila, C~ 3~-C~ 4~ alquenila, C~ 3~-C~ 4~ alquinila ou C~ 3~-C~ 6~ cicloalquila e Q representa H; -NR~ 9~R~ 10~ onde R~ 9~ e R~ 10~ representam, independentemente H; C~ 1~-C~ 4~ alquila; C~ 3~-C~ 4~ alquenila; C~ 3~-C~ 4~ alquinila; C~ 3~-C~ 6~ cicloalquila; um grupo éster; um grupo carbocíclico ou heterocíclico opcionalmente substituído; ou R~ 9~ e R~ 10~ formam um anel, quando tomados em conjunto com o nitrogênio ao qual estão anexados, o anel sendo opcionalmente substituído; e R~ 7~ representa H ou C~ 1~-C~ 6~ alquila; ou quando tomado em conjunto com o átomo ou átomos ao qual está ligado, ele é anexado a R~ 6~ e R~ 7~ formando um anal monocíclico opcionalmente substituído, possuindo 5, 6 ou 7 átomos no anel; e X representa uma ligação ou radical divalente da fórmula -(Z)~ n~(Alq)- ou -(Alq)-(Z)~ n~- onde Z representa -O-, -S- ou -NH-, alq é conforme definido em relação a R~ 6~ e n é 0 ou 1.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0305876A GB0305876D0 (en) | 2003-03-14 | 2003-03-14 | Immuno inhibitory heterocyclic compounds |
| GB0319429A GB0319429D0 (en) | 2003-08-19 | 2003-08-19 | Immuno Inhibitory Heterocyclic compounds |
| PCT/GB2004/001008 WO2004081011A1 (en) | 2003-03-14 | 2004-03-10 | Immunomodulating heterocyclic compounds |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| BRPI0408365A true BRPI0408365A (pt) | 2006-03-21 |
| BRPI0408365B1 BRPI0408365B1 (pt) | 2018-11-21 |
| BRPI0408365B8 BRPI0408365B8 (pt) | 2021-05-25 |
Family
ID=32992598
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0408365A BRPI0408365B8 (pt) | 2003-03-14 | 2004-03-10 | compostos heterocíclicos de imunomodulação |
Country Status (19)
| Country | Link |
|---|---|
| US (3) | US7276505B2 (pt) |
| EP (2) | EP2284172A1 (pt) |
| JP (1) | JP4892338B2 (pt) |
| KR (1) | KR101133959B1 (pt) |
| AT (1) | ATE489388T1 (pt) |
| BR (1) | BRPI0408365B8 (pt) |
| CA (1) | CA2519063C (pt) |
| DE (1) | DE602004030225D1 (pt) |
| DK (1) | DK1603917T3 (pt) |
| EA (2) | EA009680B1 (pt) |
| EC (1) | ECSP056104A (pt) |
| IL (1) | IL170389A (pt) |
| MX (1) | MXPA05009667A (pt) |
| NO (1) | NO332136B1 (pt) |
| NZ (1) | NZ541973A (pt) |
| PL (2) | PL1603917T3 (pt) |
| PT (1) | PT1603917E (pt) |
| SI (1) | SI1603917T1 (pt) |
| WO (1) | WO2004081011A1 (pt) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0408365B8 (pt) * | 2003-03-14 | 2021-05-25 | Avidex Ltd | compostos heterocíclicos de imunomodulação |
| GB0325644D0 (en) | 2003-11-04 | 2003-12-10 | Avidex Ltd | Immuno ihibitory pyrazolone compounds |
| GB0411770D0 (en) | 2004-05-26 | 2004-06-30 | Avidex Ltd | Immuno inhibitory heterocyclic compouds |
| DE602004017231D1 (de) * | 2004-08-09 | 2008-11-27 | Medigene Ltd | Immunmodulierende oxopyrazolocinnoline als cd80-inhibitoren |
| WO2007017289A2 (en) * | 2005-08-10 | 2007-02-15 | Bayer Schering Pharma Aktiengesellschaft | Acyltryptophanols for fertility control |
| GB0603522D0 (en) | 2006-02-22 | 2006-04-05 | Avidex Ltd | Kinase inhibition |
| BRPI0709612A2 (pt) | 2006-03-15 | 2011-07-19 | Wyeth Corp | composto de fórmula i; método para o tratamento de um distúrbio no sistema nervoso central relacionado ou afetado pelo receptor histamina-3 em um paciente que necessita deste tratamento; método para a inibição do receptor h3; composição farmacêutica; e processo para a preparação de um composto de fórmula i |
| CA2649913A1 (en) | 2006-05-19 | 2007-11-29 | Wyeth | N-benzoyl- and n-benzylpyrrolidin-3-ylamines as histamine-3 antagonists |
| EP2047848A4 (en) * | 2006-07-05 | 2010-06-09 | Univ Tokyo | METHOD FOR THE TREATMENT OF GENETIC DISEASES BASED ON A NONSENSE MUTATION |
| PE20081152A1 (es) | 2006-10-06 | 2008-08-10 | Wyeth Corp | Azaciclilaminas n-sustituidas como antagonistas de histamina-3 |
| US7803825B2 (en) | 2007-07-16 | 2010-09-28 | Wyeth Llc | Aminoalkylazole derivatives as histamine-3 antagonists |
| EP2020404A1 (en) * | 2007-08-01 | 2009-02-04 | Bayer Schering Pharma Aktiengesellschaft | Cyanomethyl substituted N-Acyl Tryptamines |
| JP5362729B2 (ja) | 2007-10-04 | 2013-12-11 | エフ．ホフマン−ラ ロシュ アーゲー | シクロプロピルアリールアミド誘導体及びその使用 |
| GB201021104D0 (en) | 2010-12-13 | 2011-01-26 | Univ Leuven Kath | Novel compounds for the treatment of neurodegenerative diseases |
| EP2676666A1 (en) | 2012-06-20 | 2013-12-25 | Eidgenössische Technische Hochschule Zürich (ETH) | Compounds for use in diagnosis or therapy of vulnerable atherosclerotic plaques |
| EP2883883A1 (en) | 2013-12-16 | 2015-06-17 | Cardio3 Biosciences S.A. | Therapeutic targets and agents useful in treating ischemia reperfusion injury |
| JP2017528461A (ja) * | 2014-09-10 | 2017-09-28 | エピザイム インコーポレイテッド | 置換ピロリジンカルボキサミド化合物 |
| JP7120549B2 (ja) | 2016-12-15 | 2022-08-17 | 小野薬品工業株式会社 | Ｔｒｅｋ（ｔｗｉｋ関連ｋチャネル）チャネルのアクチベータ |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB629412A (en) | 1946-12-24 | 1949-09-20 | Geigy Ag J R | Manufacture of metallisable monoazo dyestuffs of the pyrazolone series |
| US3576637A (en) * | 1967-04-20 | 1971-04-27 | Konishiroku Photo Ind | Lith-type of emulsion containing pyrozolone |
| JPS61161285A (ja) * | 1984-12-28 | 1986-07-21 | ルセル−ユクラフ | ピラゾロ〔４，３−ｃ〕シンノリン−３−オンの誘導体、それらの塩類、これらの製造法、薬剤としての使用、これらを含有する組成物及び中間体生成物 |
| US4591589A (en) | 1985-01-16 | 1986-05-27 | Roussel Uclaf | 2-aryl pyrazolo[4,3-c]cinnolin-3-ones |
| DE3626221A1 (de) | 1986-08-02 | 1988-02-04 | Agfa Gevaert Ag | Farbfotografisches aufzeichnungsmaterial zur herstellung farbiger aufsichtsbilder |
| EP0269030B1 (en) | 1986-11-20 | 1994-05-04 | Mitsubishi Kasei Corporation | Lipid-peroxide formation inhibiting composition and novel compounds useful therefor |
| DE3903993A1 (de) * | 1989-02-10 | 1990-08-16 | Basf Ag | Diarylsubstituierte heterocyclische verbindungen, ihre herstellung und arzneimittel daraus |
| ID16283A (id) * | 1996-03-20 | 1997-09-18 | Astra Pharma Prod | Senyawa yang berguna dibidang farmasi |
| GB9713707D0 (en) | 1997-06-27 | 1997-09-03 | Merck Sharp & Dohme | Therapeutic agents |
| SE0102404D0 (sv) * | 2001-07-04 | 2001-07-04 | Active Biotech Ab | Novel immunomodulating compounds |
| EP1411052B1 (en) | 2001-07-05 | 2011-10-05 | Takeda Pharmaceutical Company Limited | Benzo-fused 5-membered hetrocycle compounds,process for preparation of the same, and use thereof |
| US7566711B2 (en) * | 2001-10-12 | 2009-07-28 | Choongwae Pharma Corporation | Reverse-turn mimetics and method relating thereto |
| US7081456B2 (en) | 2002-11-22 | 2006-07-25 | Active Biotech Ab | Immunomodulatory compounds |
| WO2004055014A1 (en) | 2002-12-16 | 2004-07-01 | Active Biotech Ab | Tetracyclic immunomodulatory compounds |
| BRPI0408365B8 (pt) | 2003-03-14 | 2021-05-25 | Avidex Ltd | compostos heterocíclicos de imunomodulação |
| GB0325644D0 (en) * | 2003-11-04 | 2003-12-10 | Avidex Ltd | Immuno ihibitory pyrazolone compounds |
| GB0411770D0 (en) * | 2004-05-26 | 2004-06-30 | Avidex Ltd | Immuno inhibitory heterocyclic compouds |
| DE602004017231D1 (de) * | 2004-08-09 | 2008-11-27 | Medigene Ltd | Immunmodulierende oxopyrazolocinnoline als cd80-inhibitoren |
| US20060221590A1 (en) * | 2005-03-31 | 2006-10-05 | Edoardo Campini | System and method for Advanced Mezzanine Card connection |
| GB0603522D0 (en) * | 2006-02-22 | 2006-04-05 | Avidex Ltd | Kinase inhibition |
-
2004
- 2004-03-10 BR BRPI0408365A patent/BRPI0408365B8/pt not_active IP Right Cessation
- 2004-03-10 AT AT04719006T patent/ATE489388T1/de active
- 2004-03-10 EP EP10014524A patent/EP2284172A1/en not_active Withdrawn
- 2004-03-10 CA CA2519063A patent/CA2519063C/en not_active Expired - Lifetime
- 2004-03-10 PT PT04719006T patent/PT1603917E/pt unknown
- 2004-03-10 MX MXPA05009667A patent/MXPA05009667A/es active IP Right Grant
- 2004-03-10 JP JP2006505937A patent/JP4892338B2/ja not_active Expired - Lifetime
- 2004-03-10 DE DE602004030225T patent/DE602004030225D1/de not_active Expired - Lifetime
- 2004-03-10 PL PL04719006T patent/PL1603917T3/pl unknown
- 2004-03-10 WO PCT/GB2004/001008 patent/WO2004081011A1/en not_active Ceased
- 2004-03-10 EA EA200501370A patent/EA009680B1/ru not_active IP Right Cessation
- 2004-03-10 EA EA200702435A patent/EA014080B1/ru not_active IP Right Cessation
- 2004-03-10 DK DK04719006.1T patent/DK1603917T3/da active
- 2004-03-10 EP EP04719006A patent/EP1603917B1/en not_active Expired - Lifetime
- 2004-03-10 SI SI200431606T patent/SI1603917T1/sl unknown
- 2004-03-10 US US10/547,448 patent/US7276505B2/en not_active Expired - Lifetime
- 2004-03-10 PL PL383655A patent/PL383655A1/pl unknown
- 2004-03-10 NZ NZ541973A patent/NZ541973A/en not_active IP Right Cessation
- 2004-03-10 KR KR1020057017070A patent/KR101133959B1/ko not_active Expired - Lifetime
-
2005
- 2005-08-18 IL IL170389A patent/IL170389A/en active IP Right Grant
- 2005-10-13 NO NO20054710A patent/NO332136B1/no unknown
- 2005-10-14 EC EC2005006104A patent/ECSP056104A/es unknown
-
2007
- 2007-08-28 US US11/845,837 patent/US7598247B2/en not_active Expired - Lifetime
-
2009
- 2009-08-24 US US12/545,902 patent/US8309552B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0408365A (pt) | compostos heterocìclicos de imunomodulação | |
| PE20020476A1 (es) | Derivados de glucopiranosiloxibencilbenceno y composiciones farmaceuticas que comprenden los mismos | |
| WO2009010685A3 (fr) | Procede de coloration de la peau utilisant l'acide dehydroascorbique ou l'un de ses derives monomeres, polymeres ou isomeres et une amine | |
| BRPI0413861A (pt) | compostos de pirimidotiofeno | |
| ES2687368T3 (es) | Inhibidores de proteasa de epoxi cetona dipeptídica y tripeptídica | |
| WO2009057769A1 (ja) | 新規スルホン酸塩及びその誘導体、光酸発生剤並びにこれを用いたレジスト材料及びパターン形成方法 | |
| BR0309760A (pt) | polisiloxanos amino funcional e seus usos em camadas de revestimentos | |
| BRPI0506719A (pt) | composto, composição farmacêutica, e, uso de um composto | |
| WO2009150381A3 (fr) | Derives d'azacarbolines, leur preparation et leur utilisation therapeutique en tant qu'inhibiteurs de kinases | |
| EP1698624A4 (en) | phenylpropanoic acid derivatives | |
| BR0208455A (pt) | Derivados de glutaramida substituìda com n-fenpropilciclopentila como inibidores de nep para a fsad | |
| AR069509A1 (es) | Pirido (3,2-e) pirazinas, su procedimiento de preparacion y uso como inhibidores de fosfodiesterasa 10 | |
| BR9916790A (pt) | Uso de um composto, composto, processo para amanufatura do mesmo, composição farmacêtica, e,método para produzir um efeito de dano vascularem um animal de sangue quente | |
| ES2077138T3 (es) | Derivados de aminocumarano, su produccion y su uso. | |
| EA201100189A1 (ru) | Гетероарильные производные в качестве ингибиторов dgat1 | |
| BRPI0412747A (pt) | processo para preparação de anidridos cìclicos de ácido fosfÈnico | |
| ATE420847T1 (de) | Substituiertes phenylalkansäurederivat und dessen verwendung | |
| EA201190119A1 (ru) | ПРОИЗВОДНЫЕ ТРИАЗОЛОПИРИДИНА В КАЧЕСТВЕ ИНГИБИТОРОВ МАР-КИНАЗЫ p38 | |
| EA201000017A1 (ru) | Предварительная композиция серного цемента и способ приготовления предварительной композиции серного цемента | |
| BRPI0406721A (pt) | Compostos condensados de furano | |
| BRPI0414803A (pt) | derivados de ácido 4-(1-benzofuran-3-il-metilidenoaminoxi-propóxi)-benz óico e compostos relacionados como inibidores de pai-1 para o tratamento de dano do sistema fibrinolìtico e de trombose | |
| BR112014008934A2 (pt) | composição, método de obtenção da composição e formulação fitossanitária que a compreende | |
| AR042067A1 (es) | Derivados de anilinopirazol utiles en el tratamiento de la diabetes | |
| PE20071229A1 (es) | Procesos para la sintesis convergente de los derivados de caliqueamicida | |
| AR046310A1 (es) | Compuestos nucleosidicos para el tratamiento de enfermedades virales. composiciones farmaceuticas. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B25D | Requested change of name of applicant approved |
Owner name: MEDIGENE LTD. (GB) Free format text: NOME ALTERADO DE: AVIDEX LIMITED |
|
| B25A | Requested transfer of rights approved |
Owner name: MEDIGENE AG (DE) Free format text: TRANSFERIDO DE: MEDIGENE LTD. |
|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 21/11/2018, OBSERVADAS AS CONDICOES LEGAIS. |
|
| B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 10/03/2004 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |
|
| B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 21A ANUIDADE. |
|
| B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2822 DE 04-02-2025 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |